Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-043695
Filing Date
2017-07-05
Accepted
2017-07-05 18:41:00
Documents
1
Period of Report
2017-07-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7352
  Complete submission text file 0001209191-17-043695.txt   8709
Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Issuer) CIK: 0001594864 (see all company filings)

EIN.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 307 WESTLAKE AVE. NORTH, STE. 300 SEATTLE WA 98109
Business Address
Harr Steve (Reporting) CIK: 0001627387 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36781 | Film No.: 17950132